Palisade Bio, Inc. (PALI)
NASDAQ: PALI · Real-Time Price · USD
1.700
+0.010 (0.59%)
At close: Sep 17, 2026, 4:00 PM EDT
1.730
+0.030 (1.76%)
Pre-market: Sep 18, 2026, 4:00 AM EDT

Palisade Bio Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
29635055818
Market Cap Growth
5387.78%7572.39%-16.56%-31.77%-54.57%-
Enterprise Value
171345-3-9-54
Last Close Price
1.702.351.658.8578.00975.00

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
592.52--21.88--
PB Ratio
2.422.710.610.480.642.40
P/TBV Ratio
2.432.710.610.480.642.40

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-0.000.020.030.030.03
Net Debt / Equity Ratio
-1.03-1.03-1.29-1.07-0.96-1.40
Net Debt / EBITDA Ratio
3.547.390.650.940.780.88
Net Debt / FCF Ratio
6.8812.290.791.080.900.70
Asset Turnover
0.01--0.02--
Quick Ratio
23.9628.833.044.874.594.26
Current Ratio
24.2628.953.245.154.894.61
Return on Equity (ROE)
-51.37%-24.52%-153.56%-103.40%-143.72%-20012.03%
Return on Assets (ROA)
-32.98%-15.54%-74.50%-53.85%-67.69%-94.46%
Return on Capital Employed (ROCE)
-29.00%-13.90%-194.40%-112.00%-120.10%-117.20%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-10.78%-4.79%-316.35%-224.87%-177.89%-150.84%
FCF Yield
-6.14%-3.10%-267.16%-203.61%-166.78%-83.72%
Buyback Yield / Dilution
-4683.09%-3830.18%-210.62%-677.03%-370.85%-
SEC Filings: 10-K · 10-Q